Synplexity
Synplexity helps research teams accelerate biological discovery by generating broad, high-quality training datasets through large-scale mutational scanning and multiplexed gene synthesis. The company combines AI-driven sequence design with high-throughput DNA synthesis and multiplexed screening to produce broad and deep variant libraries tailored for parallel screening. Synplexity operates as a B2B biotechnology platform serving research labs and biotechs working on industrial enzymes, therapeutics, and discovery programs. Core technologies include machine learning for sequence design, large-scale DNA synthesis workflows, and multiplexed screening integrations. The platform targets organizations aiming to scale experiments and improve model-driven design cycles.
Synplexity
Synplexity helps research teams accelerate biological discovery by generating broad, high-quality training datasets through large-scale mutational scanning and multiplexed gene synthesis. The company combines AI-driven sequence design with high-throughput DNA synthesis and multiplexed screening to produce broad and deep variant libraries tailored for parallel screening. Synplexity operates as a B2B biotechnology platform serving research labs and biotechs working on industrial enzymes, therapeutics, and discovery programs. Core technologies include machine learning for sequence design, large-scale DNA synthesis workflows, and multiplexed screening integrations. The platform targets organizations aiming to scale experiments and improve model-driven design cycles.